Described as ‘one of the best teams in life sciences and healthcare in London’ Kirkland & Ellis International LLP advises a multitude of major life sciences companies on the global formulation and coordination of life science patent litigation strategy. Daniel Lim co-heads the practice and has a proven track record in pharmaceutical and medical device litigation. Fellow co-head Nicola Dagg is a known name for work including strategic patent and product lifecycle advice. Emma Flett completes the leadership team and is geared to advise on the of IP aspects of M&A transactions. SPC disputes relating to biologic and small molecule products are a practice strength of Steven Baldwin, while Jin Ooi works extensively on follow-on damages inquiry mandates.
L’éditorial du Legal 500
- Profil
- Réseaux sociaux
Distinctions
La satisfaction du client
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘The team is one of the best teams in life sciences and healthcare in London today.'
- 'The team is extremely impressive, with real strength and depth. Members of the team work seamlessly together to achieve the best outcome for the client. The team's technical, legal and commercial knowledge is exceptional. ’
‘Nicola Dagg - a star. Highly intelligent, she understands her client's needs and objectives and is able to utilise her legal talent to obtain fantastic results.'
- 'Jin Ooi - a standout member of the Kirkland team - clever, conscientious and a joy to work with. A talent with a real understanding of patent law in the healthcare field.'
‘The major strength of the life sciences team at Kirkland is the depth of their technical knowledge. It is just second to none. ’
‘I am a barrister who works with Kirkland in intellectual property cases, esp. patent litigation. The Kirkland team has great strength in life sciences cases. Like by the highly dynamic force of nature that is Nicola Dagg, clients love them and come back regularly. You only have to the look at the cases they are in and the clients they represent to see how well regarded they are. The other partners are equally strong and the associates are hardworking and bright. ’
‘Nicola Dagg is the head of the IP team and is amazing at bringing the work in she effectively manages her team to keep all the plates spinning.'
- 'Daniel Lim is excellent on medical device cases. Jin Ooi has as a nose for a good point. ’
Clients clés
- Warner-Lambert Company LLC (part of the Pfizer group)
- Viatris
- British American Tobacco (reduced risk products)
- Pfizer
- Alcon
- Advanced Bionics
- Pharmathen
- Siemens Healthineers
- Meril Life Sciences
Points forts
- Instructed by Astellas and he Regents of the University of California on an end of patent life/lifecycle management mandate in relation to Astellas’ prostate cancer treatment Xtandi.
- Successfully represented Pfizer in relation to its patent revocation action against Amgen to ‘clear the way’ for a BCMA/CD3 bispecific antibody for the treatment of cancer (in particular multiple myeloma) being developed by Pfizer.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Les grands avocats de demain
Jeunes associés disposant d’une reconnaissance montante sur le marché, jouant régulièrement un rôle clé dans des dossiers majeurs.
Responsable de la pratique
Daniel Lim; Nicola Dagg; Emma Flett
Autres avocats clés
Steven Baldwin; Jin Ooi